Back to Library
Urgent Referral

Fetal Conditions

Twin-to-Twin Transfusion Syndrome (TTTS)

Reviewed by: Dr. Werner Gerhard Diehl
12 min read
Last reviewed: 2026-06-04
15% of MC TwinsOccurrence
Laser SurgeryTreatment
16-24 WeeksDetection
Up to 90%Survival

In brief — the direct answer

Twin-to-Twin Transfusion Syndrome (TTTS) is a significant life-threatening complication that occurs exclusively in monochorionic (MC) twin pregnancies—identical twins who share a single placenta. In TTTS, microscopic blood vessel connections (anastomoses) on the placental surface create an uneven exchange of blood. One twin (the donor) continuously pumps blood to the other (the recipient), resulting in a dangerous fluid imbalance and cardiovascular stress. While untreated TTTS carries a high risk of fetal loss, modern fetal surgery has transformed this into a highly treatable condition.

Surface Connections: The Biology of TTTS

In a healthy shared placenta, blood flows symmetrically between twins. In TTTS, abnormal 'unidirectional' flow develops through vascular channels.

  • The Donor Twin: Becomes progressively dehydrated and produces minimal urine. This leads to a severe lack of amniotic fluid (oligohydramnios), often causing the twin to appear 'stuck' against the uterine wall. The donor may also experience growth restriction and anemia.
  • The Recipient Twin: Receives an excessive volume of blood, leading to a chronically overloaded circulatory system. They produce massive amounts of urine (polyhydramnios), which distends the uterus. The recipient's heart must work significantly harder to pump the extra fluid, often leading to cardiac enlargement and potential heart failure.

at the MFM Unit, we manage TTTS using the Quintero Staging System, which allows us to categorize the disease from Stage I (fluid mismatch) to Stage IV (fetal heart failure).

The Monochorionic Risk: Who is Affected?

TTTS is a risk factor only for monochorionic (MC) twins. It does not occur in fraternal (dichorionic) twins who have separate placentas.

  • The Critical Window: TTTS most commonly develops between 16 and 24 weeks of gestation, though it can occur later.
  • Prevalence: Approximately 10-15% of all MC twin pregnancies will develop TTTS.
  • The Importance of Frequency: Because TTTS can progress from a mild fluid difference to heart failure within days, international guidelines (and our Unit's protocol) require MC twins to be scanned every 2 weeks starting from 16 weeks. Missing even one of these fortnightly scans can delay life-saving intervention.

Diagnostic Criteria: Staging Fluid and Blood Flow

Diagnosis is established through specific ultrasound findings that indicate a 'Polyhydramnios-Oligohydramnios Sequence' (TOPS):

  1. Fluid Mismatch: The recipient must have a Maximum Vertical Pocket (MVP) of fluid >8cm (before 20 weeks) or >10cm (after 20 weeks), while the donor must have an MVP <2cm.
  2. Bladder Visibility (Stage II): As the condition worsens, we can no longer visualize the donor's bladder because they have ceased urine production to protect their own circulation.
  3. Doppler Abnormalities (Stage III): We use advanced Doppler to measure flow in the umbilical cord and the ductus venosus. Abnormal 'reversed flow' indicates that the twins' hearts are struggling.
  4. Hydrops (Stage IV): The final stage before fetal loss, where the recipient shows visible fluid accumulation around the heart or lungs (heart failure).

Our subspecialists utilize high-definition imaging to detect these staging markers with high precision, guiding the decision for surgery.

Surgical Intervention: The Power of Fetoscopic Laser

The definitive, gold-standard treatment for Stage II-IV TTTS is Fetoscopic Laser Ablation (FLA).

At the MFM Unit, we utilize a minimally invasive approach:

  • The Procedure: A tiny camera (fetoscope) is inserted into the womb. Guided by the screen, our surgeons identify all connecting blood vessels on the placental surface.
  • The Solomon Technique: We don't just zap individual vessels; we use the 'Solomon Technique'—drawing a continuous laser line across the placenta to ensure all microscopic connections are sealed. This effectively 'divides' the shared placenta into two separate organs.
  • Amnioreduction: At the end of the surgery, the excess fluid is drained from the recipient's sac to return the uterus to a normal size and reduce the risk of preterm labor.

Reviving Survival: Success Rates and Quality of Life

Historically, TTTS carried a survival rate of less than 10% for both babies. Today, in the hands of expert fetal surgeons like Dr. Werner Diehl, the outlook is profoundly different:

  • Survival: There is an 85-90% chance that at least one twin will survive, and a 65-70% chance that both twins will survive.
  • Neurological Health: In modern series, over 90% of survivors have normal neurological development.
  • Term Pregnancy: Most babies treated with laser surgery are delivered between 32 and 34 weeks. While they usually require a stay in our Neonatal Intensive Care Unit (NICU), they typically thrive and go on to lead healthy lives.

Successful surgery at the MFM Unit doesn't just save lives; it restores the potential for a normal childhood.

Critical Triage: When Hours Matter in Twin Care

TTTS is a clinical emergency of the womb. If you are pregnant with identical twins, you should follow a fortnightly scan schedule with an MFM specialist.

Immediate referral to our tertiary center is required if:

  • A scan shows any fluid difference between the sacs.
  • You experience sudden abdominal tightness, rapid belly growth, or new-onset shortness of breath.
  • Your local doctor mentions 'Stage I' or 'increased fluid.'

We provide the UAE's primary referral hub for fetal surgery. Our team is available 24/7 for emergency triage and intervention for twin complications across the Emirates.

Questions to ask your doctor

It is the most advanced method of laser surgery. Instead of just lasering visible vessels, we create a continuous 'fence' across the placenta. This has been proven to reduce the risk of TAPS or recurrent TTTS later in pregnancy.
Yes. In about 30% of TTTS cases, there is also Selective Fetal Growth Restriction (sFGR). After laser surgery, the donor often starts growing faster as it is no longer pumping its blood away to its twin.
For Stage I, we sometimes monitor closely without surgery (expectant management). However, for Stage II or above, laser surgery is significantly more effective than 'amnioreduction' alone at saving both babies and protecting their brains.
Most mothers stay 24 to 48 hours for observation. We then monitor you with weekly scans for the first month to ensure the twins are stabilizing as expected.
Dr. Werner Gerhard Diehl
Content Reviewer

Dr. Werner Gerhard Diehl

Senior Consultant in Maternal Fetal Medicine, Division Chief

Division Chief of the Fetal Medicine Center at Corniche Hospital, Abu Dhabi with over 35 years of clinical experience.

View Full Profile

References & Clinical Guidelines

  1. ISUOG Practice Guidelines: role of ultrasound in twin pregnancy — ISUOG (2016)
  2. Twin-Twin Transfusion Syndrome (Consult Series No. 39) — SMFM / NAFTNet (2013)
  3. Endoscopic Laser Surgery versus Serial Amnioreduction for Severe Twin-to-Twin Transfusion Syndrome (Eurofetus trial) — Senat et al. NEJM (2004)
  4. Management of Monochorionic Twin Pregnancy (Green-top Guideline No. 51) — RCOG (2016)
Share this resource